Financial disclosure at NIH and FDA

被引：0

|

作者：

不详

机构：

来源：

JOURNAL OF INVESTIGATIVE MEDICINE | 2004年 / 52卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：359 / 359

页数：1

相关论文

共 50 条

[1] FDA FINANCIAL DISCLOSURE PLAN FLOPS
FOX, JL
[J]. BIO-TECHNOLOGY, 1995, 13 (09): : 939 - 940
[2] FDA PROPOSES TO REQUIRE FINANCIAL DISCLOSURE BY CLINICAL INVESTIGATORS
NIGHTINGALE, SL
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (15): : 1160 - 1160
[3] FDA announces financial disclosure policy affecting clinical investigators
不详
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (07) : 642 - +
[4] Guidance for Clinical Investigators, Industry, and FDA Staff Financial Disclosure by Clinical Investigators
Guidance, Draft
[J]. BIOTECHNOLOGY LAW REPORT, 2011, 30 (05) : 597 - 612
[5] Guidance for Clinical Investigators, Industry, and FDA Staff: Financial Disclosure by Clinical Investigators
不详
[J]. BIOTECHNOLOGY LAW REPORT, 2013, 32 (03) : 155 - 171
[6] Disclosure for extramural NIH researchers?
Feder, Ned
[J]. SCIENTIST, 2007, 21 (02): : 15 - 15
[7] NIH disclosure rules falter
Reardon, Sara
[J]. NATURE, 2015, 525 (7569) : 300 - 301
[8] NIH disclosure rules falter
Sara Reardon
[J]. Nature, 2015, 525 : 300 - 301
[9] NIH AND FDA TEAM UP
Erickson, Britt
[J]. CHEMICAL & ENGINEERING NEWS, 2010, 88 (09) : 12 - 12
[10] Financial disclosure is not full disclosure
Goldwyn, RM
[J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 1997, 99 (07): : 2034 - 2035

← 1 2 3 4 5 →